Infectious organisms on papanicolaou smears should not influence the diagnosis of atypical squamous cells of undetermined significance

Acta Cytologica

Volumn 55, Issue 3, 2011, Pages 251-254

  Nasser, Haitham ^a   Hayek, Sylvia ^a   Balasubramaniam, Mamtha ^a   Kuntzman, Tomi J ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Atypical squamous cells of undetermined significance; Cervical dysplasia; Human papilloma virus; Infection

Indexed keywords

ARTICLE; ATYPICAL SQUAMOUS CELLS OF UNDETERMINED SIGNIFICANCE; CANCER GRADING; CARCINOMA IN SITU; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC PROCEDURE; FOLLOW UP; HERPES VIRUS; HUMAN; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PRIORITY JOURNAL; SQUAMOUS CELL; WART VIRUS; BIOPSY; EPITHELIUM CELL; FEMALE; MICROBIOLOGY; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; PATHOLOGY; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; VAGINA SMEAR; VIROLOGY; VIRUS INFECTION;

HUMAN PAPILLOMAVIRUS;

BIOPSY; EPITHELIAL CELLS; FEMALE; HUMANS; NEOPLASMS, SQUAMOUS CELL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RETROSPECTIVE STUDIES; TUMOR VIRUS INFECTIONS; VAGINAL SMEARS;

EID: 79960914803     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000323320     Document Type: Article

References (23)

1. Linder J, Zahniser D: The ThinPrep Pap test. A review of clinical studies. Acta Cytol 1997; 41: 30-38.
2. Alves VA, Bibbo M, Schmitt FC, Milanezi F, Longatto Filho A: Comparison of manual and automated methods of liquid-based cytology. A morphologic study. Acta Cytol 2004; 48: 187-193.
3. Miller FS, Nagel LE, Kenny-Moynihan MB: Implementation of the ThinPrep imaging system in a high-volume metropolitan laboratory. Diagn Cytopathol 2007; 35: 213-217.
4. Solomon D, Davey D, Kurman R, Moriarty A, O'Conor D, Prey M, et al: The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002; 287: 2114-2119.
5. Davey DD, Neal MH, Wilbur DC, Colgan TJ, Styer PE, Mody DR: Bethesda 2001 implementation and reporting rates: 2003 practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology. Arch Pathol Lab Med 2004; 128: 1224-1229.
6. Stoler MH, Schiffman M: Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASC-US-LSIL Triage Study. JAMA 2001; 285: 1500-1505.
7. Gatscha RM, Abadi M, Babore S, Chhieng D, Miller MJ, Saigo PE: Smears diagnosed as ASC-US: interobserver variation and followup. Diagn Cytopathol 2001; 25: 138-140.
8. Kurman J, Henson DE, Herbst AL, et al: The 1992 National Cancer Institute work-shop. Interim guidelines for management of abnormal cervical cytology. JAMA 1994; 271: 1866-1869.
9. Schiffman M, Herrero R, Desalle R, Hildesheim A, Wacholder S, Rodriguez AC, Bratti MC, Sherman ME, Morales J, Guillen D, Alfaro M, Hutchinson M, Wright TC, Solomon D, Chen Z, Schussler J, Castle PE, Burk RD: The carcinogenicity of human papillomavirus types reflects viral evolution. Virology 2005; 337: 76-84.
10. Cogliano V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F: Carcinogenicity of human papillomaviruses. Lancet Oncol 2005; 6: 204.
11. Misra JS, Srivastava S, Singh U, Srivastava AN: Risk-factors and strategies for control of carcinoma cervix in India: hospital based cytological screening experience of 35 years. Indian J Cancer 2009; 46: 155-159.
12. Kwaśniewska A, Korobowicz E, Zdunek M, Skoczynśki M, Kwaśniewski W, Daniloś J, Gozdzicka-Józefiak A: Prevalence of Chlamydia trachomatis and herpes simplex virus 2 in cervical carcinoma associated with human papillomavirus detected in paraffinsectioned samples. Eur J Gynaecol Oncol 2009; 30: 65-70.
13. Evans MF, Adamson CS, Schned LM, St John TL, Leiman G, Ashikaga T, Cooper K: HPV is detectable in virtually all abnormal cervical cytology samples after reinvestigation of HPV negatives with multiple alternative PCR tests. Diagn Mol Pathol 2010; 19: 144-150.
14. Moody CA, Laimins LA: Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer 2010; 10: 550-560.
15. Engberts MK, Verbruggen BS, Boon ME, van Haaften M, Heintz AP: Candida and dysbacteriosis: a cytologic, population-based study of 100,605 asymptomatic women concerning cervical carcinogenesis. Cancer 2007; 111: 269-274.
16. Miguel NL Jr, Lachowicz CM, Kline TS: Candida- related changes and ASCUS: a potential trap! Diagn Cytopathol 1997; 16: 83-86.
17. Tirone NR, Souza CE, Michelin MA, Murta EF: Frequency of infectious agents for vaginitis in patients with a cytological diagnosis of atypical squamous cells of undetermined significance. Eur J Gynaecol Oncol 2008; 29: 144-147.
18. Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D: 2006 Consensus Guidelines for the management of women with abnormal cervical screening tests. J Low Genit Tract Dis 2007; 11: 201-222.
19. Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ: 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA 2002; 287: 2120-2129.
20. Hall J, Kendall B: High risk human papillomavirus DNA detection in pap tests with both atypical squamous cells of undetermined significance and Candida. Acta Cytol 2009; 53: 150-152.
21. ASC-US-LSIL Traige Study (ALTS) Group: Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 2003; 188: 1383-1392.
22. Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ, et al: Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 1999; 281: 1605-1610.
23. Lonky NM, Felix JC, Naidu YM, Wolde-Tsadik G: Triage of atypical squamous cells of undetermined significance with hybrid capture. II. Colposcopy and histologic human papillomavirus correlation. Obstet Gynecol 2003; 101: 481-489.